Emergent BioSolutions (EBS)

Emergent BioSolutions (EBS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• EBS last traded at $6.81, -5.68% on the day.
• Emergent BioSolutions: market cap $349.17M, P/E -1.5, revenue $649.10M over the last four quarters.
• Over the past year EBS returned -46.96%; year to date -44.90%.

Updated 2026-11-03 02:01 UTC